TREVI THERAPEUTICS INC (TRVI)
US89532M1018 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.81M | 32.40M | 12.60M | 36.80M | 45.00M | |||
| Marketable Securities | 59.01M | 50.57M | 107.90M | N/A | N/A | |||
| Receivables | 721.00K | 955.00K | 1.30M | 200.00K | 300.00K | |||
| Other Current Assets | 3.23M | 3.62M | 800.00K | 900.00K | 1.00M | |||
| Total Current Assets | 76.77M | 87.55M | 122.60M | 38.00M | 46.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.48M | 1.56M | 200.00K | 200.00K | 300.00K | |||
| Other Non-Current Assets | 311.00K | 297.00K | 200.00K | 300.00K | 500.00K | |||
| Total Non-Current Assets | 1.79M | 1.86M | 400.00K | 500.00K | 800.00K | |||
| TOTAL ASSETS | 78.56M | 89.40M | 123.00M | 38.50M | 47.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 124.00K | 122.00K | 7.00M | 5.90M | N/A | |||
| Accrued Expenses | 3.04M | 3.89M | 3.00M | 3.80M | 3.40M | |||
| Accounts Payable | 2.11M | 1.81M | 2.90M | 2.80M | 2.00M | |||
| Other Current Liabilities | N/A | N/A | 500.00K | 100.00K | 200.00K | |||
| Total Current Liabilities | 5.28M | 5.82M | 13.40M | 12.70M | 5.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 31.00K | 2.20M | 8.70M | 14.20M | |||
| Other Non-Current Liabilities | 949.00K | 1.00M | 0.00 | 0.00 | 100.00K | |||
| Total Non-Current Liabilities | 949.00K | 1.03M | 2.20M | 8.70M | 14.20M | |||
| TOTAL LIABILITIES | 6.22M | 6.86M | 15.60M | 21.40M | 19.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -250.04M | -239.13M | -210.10M | -180.90M | -147.00M | |||
| Additional Paid In Capital | 322.37M | 321.64M | 317.60M | 198.00M | 174.20M | |||
| Common Shares | 69.00K | 68.00K | 100.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -67.00K | -29.00K | -100.00K | N/A | N/A | |||
| Shares Outstanding | 68.96M | 68.28M | 59.90M | 28.50M | 18.50M | |||
| Tangible Book Value per Share | 1.05 | 1.21 | 1.79 | 0.60 | 1.48 | |||
| Total Shareholders' Equity | 72.33M | 82.55M | 107.50M | 17.10M | 27.30M | |||
| TOTAL LIABILITIES AND EQUITY | 78.56M | 89.40M | 123.00M | 38.50M | 47.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | 0.02 | 0.51 | 0.52 | |||
| Current Ratio | 14.55 | 15.03 | 9.15 | 2.99 | 8.27 | |||
| Return On Assets (ROA) | -42.74% | -32.51% | -23.70% | -88.16% | -69.55% | |||
| Return On Equity (ROE) | -46.41% | -35.21% | -27.12% | -198.48% | -120.00% | |||
All data in USD